Morgan Keegan Lowers Estimates On VCA Antech

According to Morgan Keegan, VCA Antech WOOF reported second quarter EPS of $0.45, in line with estimate and $0.01 above consensus, while same-store sales were slightly weaker than estimated. Morgan Keegan said that it has found VCA Antech's same-store growth to be highly correlated to consumer confidence, which remains weak. “We are lowering same-store growth assumptions going forward, assuming a slower ramp. As a result, we are lowering our 2012 EPS estimate from $1.72 to $1.62. We are also substituting a 15x (1x PEG) target multiple for our prior 17x, resulting in a $23 price target. We would wait for higher consumer confidence before buying shares.” VCA Antech closed yesterday at $19.89.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsHealth CareHealth Care FacilitiesMorgan Keegan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!